We used the Sleeping Beauty (SB) transposable element as a tool to probe transposon-host cell interactions in vertebrates. The Miz-1 transcription factor was identified as an interactor of the SB transposase in a yeast two-hybrid screen. Through its association with Miz-1, the SB transposase down-regulates cyclin D1 expression in human cells, as evidenced by differential gene expression analysis using microarray hybridization. Down-regulation of cyclin D1 results in a prolonged G 1 phase of the cell cycle and retarded growth of transposase-expressing cells. G 1 slowdown is associated with a decrease of cyclin D1͞cdk4-specific phosphorylation of the retinoblastoma protein. Both cyclin D1 down-regulation and the G 1 slowdown induced by the transposase require Miz-1. A temporary G 1 arrest enhances transposition, suggesting that SB transposition is favored in the G 1 phase of the cell cycle, where the nonhomologous end-joining pathway of DNA repair is preferentially active. Because nonhomologous end-joining is required for efficient SB transposition, the transposase-induced G 1 slowdown is probably a selfish act on the transposon's part to maximize the chance for a successful transposition event.
M
obility of transposable elements is regulated by both hostand element-encoded factors, which operate by imposing constraints on transposition. Members of the Tc1͞mariner superfamily of elements are probably the most widespread DNA transposons in nature, including vertebrates (1) . By far the most active Tc1͞mariner element in vertebrates is the Sleeping Beauty (SB) transposon, a reconstructed version of an ancient and extinct element in teleost fish (2) . SB transposition is efficient in cells of different vertebrate classes in tissue culture (3) and in somatic (4) as well as germline tissues (5) 
of the mouse in vivo.
SB transposition is initiated by binding of the transposase to binding sites located within the terminal inverted repeats of the element. The two ends of the element are then probably paired through interactions of transposase subunits (6) , thereby forming a synaptic complex, in which excision of the transposon from the donor site likely occurs. The reaction is completed after reintegration of the element into a target site, followed by repair of transposon-induced DNA lesions by the host repair machinery.
Interactions of components of the transposable element with host factors likely play important roles in the transposition process, at any of the steps described above. Indeed, we previously identified the HMGB1 protein as a cofactor of SB transposition in mammalian cells (7) . HMGB1 interacts with the SB transposase in vivo and is probably involved in synaptic complex formation during transposition (7) . SB transposase also interacts with the Ku protein, a component of the nonhomologous end-joining (NHEJ) pathway of double-strand DNA break repair (8) , which is a limiting factor of SB transposition (8) .
Transposon excision sites are preferentially repaired by NHEJ in mammalian somatic cells (8, 9) .
To investigate cellular responses to transposition, and to identify host-encoded factors that mediate such responses, we applied both a microarray analysis of gene expression of human cells undergoing efficient transposition and a yeast two-hybrid screen for proteins that interact with the transposase. We show that the SB transposase interacts with Miz-1 and down-regulates cyclin D1 expression in a Miz-1-dependent manner resulting in a slowdown of the cell cycle in the G 1 phase. Miz-1 is a transcriptional regulator of genes involved in cell-cycle regulation (10) (11) (12) , including cyclin D1 (13) . We show that a temporary G 1 arrest increases the efficiency of transposition. Based on these findings, we propose a model in which SB transposition preferentially occurs in the G 1 phase of the cell cycle, where transposon-induced DNA damage can be efficiently repaired by NHEJ.
Results

A Yeast Two-Hybrid Screen Identifies the Myc-Interacting Zinc Finger
Protein 1 as a Specific Interactor of the SB Transposase. Interactions of the SB transposase with cellular proteins might affect the transposition reaction as well as endogenous cellular processes. We previously established that the SB transposase interacts with the DNA-bending protein HMGB1 (7) and the DNA-repair protein Ku (8) in vivo.
In searching for additional SB interactors, a human HeLa cDNA library fused to the GAL4 activation domain (AD) was screened by using the yeast two-hybrid technology, with the full-length SB transposase fused to GAL4 DNA-binding domain (BD) as the bait. One cDNA that conferred activation of yeast reporter genes encoded a truncated version of the human Myc-interacting zinc finger protein 1 (Miz-1). Miz-1 is a Mycassociated transcription factor (13) and a potent cell-cycle regulator (11) . SB transposase͞Miz-1 interaction was verified by using both the full-length Miz-1 protein and a truncated version lacking the N-terminal 268 aa by cotransformation with the SB bait construct into yeast cells. Both Miz-1 versions supported interaction with SB (Fig. 1A, experiments 1 and 2) . Thus, similar to the interaction of Miz-1 to Myc (13) , the N-terminal region of Miz-1 does not contribute to the binding of Miz-1 to the transposase. Indeed, the N-terminal 268 amino acids including the BTB͞POZ domain of Miz-1 do not interact with the SB transposase (experiment 3). Specificity of the interaction was demonstrated by coexpression of GA L4-BD͞SB with GA L4-AD (experiment 4), and GA L4-AD͞Miz-1 with GAL4-BD (experiment 5), which did not result in reporter gene activation. Consequently, both Miz-1 and SB transposase are required for interaction. It has to be noted that a human cell is not a natural environment for the SB transposase that is originated from fish. An amino acid sequence alignment of the vertebrate Miz-1 orthologs currently available in the databases shows a remarkable conservation (e.g., 73% identity and 78% similarity between human and zebrafish) of the region involved in the interaction with the SB transposase (Fig. 7 , which is published as supporting information on the PNAS web site). Therefore, the SB transposase is expected to interact with Miz-1 in diverse vertebrate species.
A physical interaction between the SB transposase and Miz-1 was further investigated in vitro, using a maltose binding protein-SB transposase fusion protein (MBP-SB) immobilized on amylose beads and incubated with radioactively labeled Miz-1. As shown in Fig. 1B , Miz-1 was specifically retained on MBP-SB beads (lane 2) but not on control MBP beads (lane 3), confirming the interaction between SB transposase and Miz-1.
In vivo interaction was confirmed by immunoprecipitation with a human Miz-1 antibody, blotting, and hybridization with an antibody against SB transposase or with cyclin D1 and actin antibodies as controls. SB transposase was coprecipitated with the Miz-1 antibody but not with a control actin antibody (Fig. 1C,  lanes 1 and 2) . Treatment of extracts with Miz-1 antibody failed to immunoprecipitate cyclin D1 and actin, indicating that the interaction observed is specific for the SB transposase (Fig. 1C,  lanes 3 and 4) . Taken together, the results establish a specific interaction between SB transposase and Miz-1.
SB Transposase Down-Regulates Cyclin D1 Expression in Human Cells.
Miz-1 is a transcription factor of several cell-cycle regulatory genes (11) (12) (13) . Therefore, an interaction of Miz-1 with the SB transposase might result in changes in cell-cycle progression. To identify such pathways, we investigated differential gene expression in cells undergoing transposition, using microarray analysis. A HeLa-derived transgenic cell line (IRES-SB) stably expressing the SB transposase (3) and control cells (IRES-K) carrying only the integrated empty expression vector were transfected with a GFP-tagged transposon plasmid (pT͞GFP), which can undergo transposition in IRES-SB cells. To distinguish changes in cellular gene expression that are specific for transposition events from those that arose because of the presence of the transposase, we also included untransfected IRES-SB cells in the analysis.
Affymetrix HGU95A GeneChips were used for hybridization, and Fig. 2 shows average changes in transcript levels of selected cell-cycle genes in the presence of either the transposase only or the transposase plus transposon DNA, as compared with samples without the transposase. Transcriptional changes of most cyclins and cyclin-dependent kinase (cdk) inhibitors were within the range of the housekeeping gene ␤-actin and thus are not considered significant. In contrast, a handful of known cell-cycle regulatory genes did produce significant changes. These include the retinoblastoma (Rb), CGR11, GAS1, and PLAGL1 genes. Finally, in the presence of the transposase, there is a 4-to 7-fold decrease in cyclin D1 mRNA levels (Fig. 2) . Interestingly, changes in cyclin D1 transcript levels do not seem to depend on the presence of transposon DNA and are apparently due to the mere presence of the transposase. This observation indicates that the effect on cyclin D1 expression, and thus on the cell-cycle profile of transposase-expressing cells, is not associated with a cellular response to transposition-induced DNA damage.
From the affected cell-cycle regulatory genes, cyclin D1 is an established target of Miz-1 (13) . Therefore, we decided to characterize SB's effect on the cyclin D1 gene in more detail. The effect of the SB transposase on cellular cyclin D1 levels was validated by Western blot hybridization. As shown in Fig. 2 , cyclin D1 protein levels are reduced Ϸ2-fold in IRES-SB cells as compared with control cells. These findings suggest that the SB transposase can down-regulate cyclin D1 expression and thereby has the potential to modulate cell-cycle progression.
Cells Expressing the SB Transposase Exhibit Retarded Growth Due to
the Accumulation of Cells in the G1 Phase of the Cell Cycle. D-type cyclins are required for progression through the G 1 phase of the cell cycle (14) . Decreased cellular levels of cyclin D1 prevent cells from entering the S phase, resulting in cell-cycle arrest in the G 1 phase (15) . Thus, because cells expressing the SB transposase have decreased levels of cyclin D1, they are expected to exhibit reduced growth associated with an increase in G 1 cell population.
The growth rates of stable IRES-SB and IRES-K transgenic derivatives of the human hepatoma cell line HuH7 were com- Cell-cycle arrest can be a cellular response to transposaseinduced DNA damage. To investigate this possibility, the growth rates of transgenic cells stably expressing two catalytically inactive mutant versions of the SB transposase were also examined. These mutations (D244A and E279D) affect amino acid residues of the conserved DDE domain that are required for the catalytic activities of a large number of recombinase proteins, including retroviral integrases, the RAG1 V(D)J recombinase, and the Tc1͞mariner family of transposases including SB (1, 4) .
In a colony-forming assay, multiple colonies formed on plates transfected with the empty control construct. In contrast, expression of both the wild-type transposase and the catalytically inactive transposase mutants severely suppressed colony formation (Fig. 3A) . Thus, the ability of the SB transposase to induce retarded growth does not require its catalytic activity. In an independent approach, we engineered two human sequences on chromosomes 8 and 15 showing significant similarity to the transposase binding sites within the terminal inverted repeats of the transposon (Fig. 8A , which is published as supporting information on the PNAS web site) into SB vectors, in such a way that they precisely replaced the terminal sequences at the right end of the transposon. Neither construct showed activity in transposon excision assays (Fig. 8B) , suggesting that endogenous human sequences are not mobilized by the SB transposase. Taken together, we conclude that the altered growth characteristics of transposase-expressing cells cannot be associated with a cellular response to DNA damage.
Flow cytometry was applied to analyze the cell-cycle profiles of IRES-SB and IRES-K cells. Cells expressing the transposase showed a 7-11% increase in the G 0 ͞G 1 -phase cell population compared with control IRES-K cells (Fig. 3B ). This effect is quite significant, in light of the 19% increase in G 0 ͞G 1 of transgenic cells overexpressing Miz-1, a potent cell-cycle regulator (11) . Accumulation of SB-expressing cells in G 0 ͞G 1 was accompanied by a decrease in S-phase cells, whereas the G 2 ͞M population appeared to be largely unaffected (Fig. 3B) . These data suggest that SB transposase can slow down the cell cycle specifically in the G 1 phase, at least in part due to downregulation of the cyclin D1 gene.
G1 Slowdown Is Associated with Decreased Levels of Phosphorylated
Retinoblastoma Protein in Cells Expressing the SB Transposase. A downstream target of the different cyclin-cdk complexes acting in G 1 is Rb, which is expressed throughout the cell cycle at a fairly steady level, but its phosphorylation state changes in a phasespecific manner (16) . During G 1 , phosphorylation of Rb by specific cyclin-cdk complexes inhibits the growth-suppressive function of Rb, which allows the cell to enter the S phase (17, 18).
We examined levels of phosphorylated Rb in transposaseexpressing and control cells. Western blot hybridizations with antibodies raised against phospho-Rb (Ser-780) and phospho-Rb (Ser-807͞811) were done. These serine residues are specifically phosphorylated by cyclin D1-cdk4 but not by cyclin E-cdk2 and cyclin A-cdk2 (19) , and therefore serve as useful indicators of cyclin D1-mediated cdk activity. Fig. 3C shows a significant decrease in Rb phosphorylated at both the Ser-780 and the Ser-807͞811 sites in HuH7 cells expressing the SB transposase. The decreased levels of hyperphosphorylated (i.e., growth-promoting) Rb in cells expressing the transposase provide evidence that transposase-induced G 1 slowdown is mediated by the Rb pathway.
Regulation of the Cyclin D1 and p15 INK4b Promoters by Miz-1 and SB Transposase. The above results establish an impact of the SB transposase on cell-cycle progression and indicate that this impact is brought about, at least in part, by a decrease in cyclin D1 gene activity. Miz-1 was described previously as a transcriptional regulatory protein capable of activating the adenovirus major late (AdML), cyclin D1, and p15 INK4B promoters (11, 13) . However, impaired transactivation of these promoters by Miz-1 was observed when coexpressed with Myc (11, 13) . These findings led us to hypothesize that SB transposase might exert an effect similar to Myc; namely, that through its interaction with Miz-1, SB might mediate repression of cell-cycle regulatory genes such as cyclin D1 or p15 INK4b .
We investigated the activities of the cyclin D1 and p15 INK4b promoters in transient reporter assays. HeLa cells were cotransfected with cyclin D1-and p15 INK4b promoter-driven luciferase reporter constructs (11, 20) together with the pCMV-Miz-1 expression plasmid either alone or in combination with constructs expressing Myc or SB. Miz-1 activates the cyclin D1 promoter (Fig. 4A, compare lanes 1 and 2) , consistent with published results (13) . An N-terminally truncated Miz-1 protein (containing amino acids 269-803) that retains its ability to interact with SB transposase (Fig. 1 A) transactivates the cyclin D1 promoter at a level comparable with the full-length Miz-1 protein (lane 3). Next we examined the ability of SB transposase to repress Miz-1-mediated transcriptional activation. First, the SB transposase alone does not repress expression from the cyclin D1 promoter (lane 4). As expected, coexpression of Myc antagonizes the activating effect of Miz-1 (lane 5). Significantly, coexpression of the SB transposase with Miz-1 led to a 3-fold decrease of luciferase expression from the cyclin D1 promoter 
(A) Growth curves of HuH7 cells expressing SB transposase (IRES-SB) and cells containing the empty vector (IRES-K), established in experiments done in triplicate. The colony-forming assay (six independent platings) shows stained colonies of cells transfected with the empty control (IRES-K), catalytically active SB transposase (IRES-SB), and catalytically inactive SB mutants [IRES-SB (DAE) and IRES-SB (DDD)]. (B) FACScan profiles of IRES-SB and IRES-K cells. Stable expression of SB transposase in IRES-SB cells was verified by Western blot analysis. (C) Levels of phosphorylated retinoblastoma protein in IRES-K and IRES-SB cells were analyzed by
Western blot hybridization with antibodies raised against phospho-Rb (Ser-780) and phospho-Rb (Ser 807͞811).
(lane 6). However, only minimal repression was observed in the presence of Miz-1 (269-803) (lane 7). This finding suggests that cyclin D1 repression by the SB transposase requires the intact Miz-1 protein. Miz-1 also activates the p15 INK4b promoter (Fig.  4B, compare lanes 1 and 2) , as previously published (11) . However, in contrast to the cyclin D1 promoter, the activity of the p15 INK4b promoter remained relatively unaffected in the presence of the transposase (lane 3), although the reported repressing ability of Myc (11) was clearly reproduced (lane 4). These data show that down-regulation of the cyclin D1 promoter requires both the transposase and Miz-1, and that, unlike Myc, the SB transposase does not affect expression of the p15 INK4b gene. We addressed this hypothesis by knocking down Miz-1 expression using RNA interference with a short hairpin RNA that was shown before to be a potent down-regulator of Miz-1 in human cells (21) . We validated the functionality of this construct using the p15
INK4b promoter activation assay (data not shown). We investigated the effect of stable Miz-1 knockdown on the cell-cycle profiles of IRES-SB and IRES-K cells. As shown in Fig. 5A , knockdown of endogenous Miz-1 abrogates the SB transposase-induced G 1 slowdown in IRES-SB cells but does not influence the cell-cycle profiles of IRES-K cells. The effect of Miz-1 knockdown on cyclin D1 expression was also analyzed. Consistent with our earlier findings (Fig. 2) , cyclin D1 expression is reduced in IRES-SB cells in the absence of Miz-1 short hairpin RNA (Fig. 5B) . However, cyclin D1 levels return to normal when the short hairpin RNA directed against Miz-1 is expressed in IRES-SB cells (Fig. 5B) . We conclude that Miz-1 is required for transposase-mediated G 1 slowdown as well as for downregulation of cyclin D1 expression. To investigate whether a transposase-induced G 1 slowdown has an impact on the efficiency of transposition, a quantitative transposition assay was performed in CHO-K1 cells that readily respond to serum starvation in a reversible manner. The transposition assay is based on transfection of a donor plasmid carrying an antibiotic resistance gene (neo)-marked transposon with or without a helper plasmid into cultured cells. Cells are placed under antibiotic selection, and the numbers of resistant colonies are counted. The ratio between numbers obtained in the presence versus the absence of transposase provides a measure of the efficiency of transposition (2) . CHO-K1 cells were subjected to serum withdrawal 1 day after transfection, which resulted in an enrichment of a population of cells in the G 1 phase, as determined by FACS analysis (Fig. 6A) . As shown in Fig. 6B , there was an Ϸ50% increase in transposition efficiency in serum-starved cells. Equal expression of SB transposase in G 1 -arrested and normally proliferating cells was demonstrated by Western blotting (Fig. 6C) . We conclude that an artificially induced block in the G 1 phase of the cell cycle enhances SB transposition, suggesting that SB's natural ability to slow down the cell cycle is beneficial for the transposition process. 
Discussion
Here we demonstrate that the human Miz-1 protein is an interactor of the SB transposase (Fig. 1) . Transcriptional activation of the cyclin D1 and p15
INK4b promoters is inhibited when Myc forms a complex with Miz-1 (11, 13), suggesting a role of Miz-1 in gene repression by Myc. Based on these previous studies, we assumed that the SB transposase might exert a function similar to Myc; namely, transcriptional regulation of cell-cycle regulatory genes.
We established that the SB transposase induces a Miz-1-dependent slowdown of the cell cycle in the G 1 phase in proliferating cells (Figs. 3 and 5) . Several lines of observation suggest that cyclin D1 is a key mediator of SB's effect on the cell cycle: (i) cyclin D1 expression is down-regulated in cells expressing the SB transposase (Figs. 2 and 5 ), (ii) SB transposase specifically represses the cyclin D1 promoter in transient reporter assays (Fig. 4A) as well as endogenous cyclin D1 expression (Fig. 5B ) in a Miz-1-dependent manner, and (iii) cells expressing the transposase have reduced levels of retinoblastoma protein phosphorylated at cyclin D1͞cdk4 target sites (Fig. 3C) . Although DNA damage can induce cell-cycle arrest, our results are inconsistent with the G 1 -specific slowdown being elicited by DNA damage. First, the presence of the SB transposase in cells is sufficient to trigger cyclin D1 down-regulation (Fig. 2) , indicating that the effect is not due to transposition-induced DNA damage. Second, HeLa cells, in which the p53-p21 G 1 damage-checkpoint is inactivated (22) , can apparently undergo SB transposase-induced G 1 slowdown (data not shown). Finally, catalytically inactive transposase mutants also have the capacity to induce retarded cell growth (Fig. 3A) , indicating that SB's effect on the cell cycle is not associated with its catalytic activity. Our results are therefore consistent with the suggestion that G 1 slowdown by the transposase is due to cyclin D1 downregulation, although the involvement of other cell-cycle regulatory genes cannot be excluded.
The SB transposase-induced G 1 slowdown is beneficial for transposition, because increased transpositional activity was observed in G 1 -arrested cells (Fig. 6 ). This observation implies that the SB transposon actively interferes with cell-cycle progression for its own benefit. Other parasitic genetic elements have also developed versatile strategies to perturb the cellular machinery to maximize their chance for survival and propagation. For example, infection by the HIV type 1 (HIV-1) blocks cellular proliferation at the G 2 phase, triggered by the HIV-1 gene product Vpr (23) . Herpes simplex virus (24), cytomegalovirus (25) , and Epstein-Barr virus (26) slow down the G 1 ͞S transition phase to allow ample opportunity for expression of viral genes before the onset of cellular genomic replication. For example, the Kaposi's sarcoma-associated herpesvirus K-bZIP protein physically associates with cyclin-CDK2 and downregulates its kinase activity. The result of this association is a prolonged G 1 phase (27) . Intriguingly, mouse hepatitis virus replication was shown to induce a reduction in the amounts of cyclin-cdk complexes, resulting in insufficient phosphorylation of Rb, and an inhibition of the cell cycle in the G 1 phase (28) . Thus, overriding the normal cell-cycle program seems to be a shared strategy of many molecular parasites.
Delay in the G 1 ͞S transition and S phase progression by cell-cycle checkpoints is thought to facilitate DNA repair to avoid replication and subsequent propagation of potentially hazardous mutations. In eukaryotic cells, double-strand DNA breaks can be repaired by at least two pathways, homologous recombination and NHEJ. The two pathways are complementary but act at different stages of the cell cycle: NHEJ is preferentially active in the G 1 and early S phases (29) , whereas homologous recombination is active in the late S and G 2 phases (30) . Accordingly, there is increasing evidence for a correlation between the particular pathway used for the repair of transposon-induced DNA damage and the cell-cycle stage where recombination occurs. This correlation is nicely illustrated by gene rearrangements through V(D)J recombination, which is tightly linked to the G 1 phase of the cell cycle and to NHEJ (31, 32) .
It was recently shown that double-strand DNA breaks generated by SB transposition are preferentially repaired by the NHEJ pathway (8, 9) . Based on our findings, we propose a model in which SB transposase induces a cyclin D1-dependent G 1 slowdown in proliferating cells through interaction with Miz-1, thereby ensuring that transposon-induced DNA damage is repaired by NHEJ. In nature, preferential use of NHEJ for the repair of transposon-induced double-strand DNA breaks might help in avoiding homologous recombination events between dispersed copies of transposable elements in the genome, thereby assisting the maintenance of genomic stability.
Materials and Methods
Two-Hybrid Screen and Interaction Domain Mapping. A HeLa cDNA library (Matchmaker; Clontech) was screened according to the manufacturer's instructions. Mapping constructs were cotransformed into the yeast reporter strain AH109 (Clontech). Yeast clones containing both plasmids were selected and subsequently plated onto medium selecting for protein-protein interaction.
MBP Pull-Down Assay. MBP-SB and MBP protein expression was induced in Escherichia coli strain BL21, and proteins were bound to amylose resin (NEB), which were equilibrated in binding buffer [20 mM Hepes, pH 7.5͞0.4 M KCl͞25% (vol/vol) glycerol͞1 mM EDTA͞2 mM MgCl 2 ͞5 mM DTT]. In vitro translation of Miz-1 was performed with rabbit reticulocyte lysate (Promega) and [ 35 S]methionine (Amersham Pharmacia). Radiolabeled protein was added to the MBP-SB-and MBP-bound resin, incubated, and washed with binding buffer containing 60 mM KCl without BSA. The proteins were resolved on a 12.5% SDS-polyacrylamide gel.
Transfections. Cells were transfected by using FuGENE6 (Roche). The pIRES-SB and pIRES-hyg constructs were trans- fected into HuH7 cells, which were selected in the presence of 150 g͞ml hygromycin. A large number (Ͼ100) of individual, antibiotic-resistant clones were pooled, expanded, and checked for transposase expression by Western blot hybridization. Transfected CHO-K1 cells were incubated for 24 h in serumcontaining medium to allow uptake of plasmid DNA into the nucleus. G 1 arrest was induced by exchanging the medium for DMEM supplemented with 0.5% FBS and incubation for 48 h. To select for transgene integration, cells were grown in medium containing 1,000 g͞ml G418 (BRL). For stable Miz-1 knockdown, HuH7-derived IRES-SB and IRES-K cells were cotransfected with 50 ng each of pFP-H1-Miz-1 or pFP-H1 (control) and the FP transposase-expressing helper plasmid pFV-FP (33). After 2 weeks of selection using 1,000 g͞ml G418, a large number of colonies of each line was pooled, expanded, and subjected to FACS analysis.
Reporter Gene Assays. HeLa cells were transfected with luciferase reporter constructs, pCMV-SB (2) or pCMV (as control) and pCMV-␤ as an internal control for transfection efficiency. Two days after transfection, cells were lysed in 25 mM Tris-phosphate (pH 7.8), 2 mM DTT, 2 mM CDTA, 10% glycerol, and 1% Triton X-100, and luciferase activity was measured. For ␤-galactosidase assay, protein extracts were mixed with buffer containing 100 mM Hepes (pH 7.3), 150 mM NaCl, 4.5 mM L-aspartate (hemi-Mg salt), 1% BSA, 0.05% Tween 20, and 1.6 mM chlorophenol red ␤-D-galactopyranoside. The reaction was stopped with 0.5 ml of 3 mM ZnCl 2 , the reaction time was recorded, and OD 578 was measured. Units of ␤-galactosidase were calculated as the changes of OD 578 per reaction time and amount of total protein harvested.
Cell-Cycle Analyses. Growth curves were determined by seeding out 50 ϫ 10 3 cells per well of a six-well plate. At various time points, cell numbers were determined by hematocytometry. In colony-forming assays, equal numbers of cells expressing either the wild-type SB transposase or catalytically inactive transposase mutants were put in selective medium 48 h after transfection, and surviving colonies were stained after 16 days of antibiotic selection. Cell-cycle stages were determined by propidium iodide staining and FACS, using standard protocols.
Retinoblastoma Protein Phosphorylation and Immunoprecipitation.
Total protein extracts were submitted to Western blot hybridizations by using phospho-Rb (Ser-780) and phospho-Rb (Ser-807͞811) antibodies (Cell Signaling Technology). For loading control, anti-actin Mab-5 antibody (NeoMarkers) was used. The HeLa-derived IRES-SB cell line was transfected with CMVMiz-1 (wild type). Two days after transfection, precleared total protein extracts were prepared, and immunoprecipitation was performed by using an anti-Miz-1 (10E2, mouse monoclonal; kind gift from M. Eilers, University of Marburg) or anti-actin (Ab-5, Dianova) antibodies. The beads were washed, resuspended in SDS sample buffer, and subjected to Western blot hybridization.
Affymetrix GeneChip Hybridizations. HeLa[IRES-SB] (3) and [IRES-K] cells were transfected with pT͞GFP. Forty-eight hours after transfection, total cellular RNA was isolated from cells of two independent experiments. Sample processing and labeling was according to ref. 34 . Samples were hybridized to Affymetrix GeneChips (HGU-95AV2) according to the manufacturer's instructions. Data were collected by a laser-scanning technique and analyzed by using MICROARRAY SUITE 5.0 software (Affymetrix). The fold change values derived from the background noise were excluded from the analysis.
